Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Mid-range Performer
5433.0000
-75.00
(
-1.36
%)
NSE
Sep 26, 2025
15:31 PM
Volume:
181.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
08 Aug 2020
5433.00
-1.36%
Alkem Labs (BUY): Gross margin beat sustainable; stronger FCF to support rerating
Buy:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3600
Target
BOB Capital Markets Ltd.
Alkem Labs posted a solid Q1 EBITDA beat led partly by one-offs.
Alkem Laboratories L.. has an
average target
of 5463.50 from 2 brokers.
More from Alkem Laboratories Ltd.
Recommended
The new H1B fee: Who will it hurt the most?
The Baseline |
26 Sep 2025, 05:06PM
Five Interesting Stocks Today - September 26, 2025
The Baseline |
26 Sep 2025, 04:56PM
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021